Tag: Alpha-Synuclein

The Michael J. Fox Foundation for Parkinson’s Research Finds Parkinson’s Biomarker

Breaking News: Critical Advance Announced in Imaging the Living Parkinson’s Brain

News in Context: New Drug Approved for Alzheimer’s Disease

Potential Therapy Targeting Key Parkinson’s Protein Advances in Human Trials

The PASADENA Study – Targeting Alpha-synuclein

Understanding Alpha-Synuclein and it’s role in Parkinson’s

New Alpha-Synuclein Therapy Begins Clinical Trial

Update on Alpha-Synclein Therapies in Clinical Trials

Measuring Parkinson’s Protein Throughout Body

Important PPMI Results Highlighted in USA Today